Stay updated with breaking news from Mci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Elecsys beta-amyloid (1-42) CSF II and Elecsys phospho-tau (181P) CSF assays are for use in adults aged 55 and older who are being evaluated for cognitive difficulties.
A Lancet editorial calls for 'tempering hype and hope' over lecanemab for Alzheimer's disease, which provided modest benefit with safety concerns in the CLARITY AD trial.
A large meta-analysis provides the best evidence to date that hearing restorative devices reduce the risk for cognitive decline and dementia and even improve short-term cognitive function
Researchers have identified a biomarker found in urine that was significantly elevated in patients with Alzheimer's disease, including those in the very early stages of the disease.
Novel longitudinal data confirm accelerated biomarker changes during preclinical AD and highlight the important role of amyloid levels in tau accelerations.